(Memphis) Josh Hardy, the 7-year-old boy at St. Jude who received an unapproved drug to kill a severe infection, is responding to that drug in an amazing way.
Josh is being treated in Memphis at St. Jude.
Today his mother, Aimee told WREG’s Jessica Gertler, “Glory to GOD the medicine is working! Before Josh took the medicine, the adenovirus showed up in his blood in 250,000 log copies. Yesterday, after only 2 doses (Wednesday and Saturday), the log copies are down to 1,000! If it stays on this course, it should be gone by next Monday!!!!”
Since Josh was 9 months old, he has beat cancer four times.
When he got a bone marrow transplant last year, Josh faced another battle, he caught an adenovirus that spread through his body.
On March 11, Aimee told us, “He had the bone marrow cells administered January 10. On January 14, we went to the ICU, and we have been there since. He had heart failure, kidney failure and major lung issues.”
Brincidofovir is not approved by the FDA but is being used under a special protocol.